{"id":"vinblastine-prednisone","safety":{"commonSideEffects":[{"rate":"30-50%","effect":"Neutropenia"},{"rate":"20-40%","effect":"Thrombocytopenia"},{"rate":"10-30%","effect":"Anemia"},{"rate":"50-70%","effect":"Nausea and vomiting"},{"rate":"20-40%","effect":"Diarrhea"},{"rate":"10-30%","effect":"Fatigue"},{"rate":"10-30%","effect":"Infection"},{"rate":"1-5%","effect":"Steroid-induced psychosis"}]},"_chembl":{"chemblId":"CHEMBL159","moleculeType":"Small molecule","molecularWeight":"810.99"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Vinblastine works by binding to tubulin and preventing the formation of microtubules, which are essential for cell division. This leads to cell cycle arrest and apoptosis in rapidly dividing cancer cells. Prednisone, on the other hand, has anti-inflammatory and immunosuppressive effects, which can help to reduce inflammation and prevent the immune system from attacking the body's own tissues.","oneSentence":"Vinblastine is a vinca alkaloid that inhibits microtubule formation in the mitotic spindle, thereby inducing cell cycle arrest at the metaphase and apoptosis. Prednisone is a corticosteroid that has anti-inflammatory and immunosuppressive properties.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:54:46.714Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hodgkin's lymphoma, Non-Hodgkin's lymphoma, Testicular cancer, Hodgkin's disease"}]},"trialDetails":[{"nctId":"NCT05675410","phase":"PHASE3","title":"A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2023-05-11","conditions":"Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8","enrollment":1875},{"nctId":"NCT07431060","phase":"NA","title":"Modified LCH-III Regimen With or Without Luvometinib for Multisystem Pediatric Langerhans Cell Histiocytosis","status":"RECRUITING","sponsor":"West China Second University Hospital","startDate":"2026-02-13","conditions":"Langerhans Cell Histiocytosis (LCH)","enrollment":120},{"nctId":"NCT03755804","phase":"PHASE2","title":"Pediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17","status":"ACTIVE_NOT_RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2018-12-12","conditions":"Hodgkin Lymphoma","enrollment":232},{"nctId":"NCT03407144","phase":"PHASE2","title":"Safety and Efficacy of Pembrolizumab (MK-3475) in Children and Young Adults With Classical Hodgkin Lymphoma (MK-3475-667/KEYNOTE-667)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2018-04-09","conditions":"Hodgkin Lymphoma","enrollment":340},{"nctId":"NCT00846742","phase":"PHASE2","title":"Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Favorable-Risk Hodgkin Lymphoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2009-06-05","conditions":"Hodgkin Lymphoma","enrollment":88},{"nctId":"NCT07209059","phase":"PHASE2","title":"PET-Adapted First-Line Therapy With Nivolumab for Advanced Hodgkin Lymphoma","status":"RECRUITING","sponsor":"National Research Center for Hematology, Russia","startDate":"2025-07-29","conditions":"Hodgkin Lymphoma, Hodgkin Disease, Advanced Hodgkin Lymphoma","enrollment":30},{"nctId":"NCT02670707","phase":"PHASE3","title":"Vinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH)","status":"RECRUITING","sponsor":"Baylor College of Medicine","startDate":"2016-03-07","conditions":"Langerhans Cell Histiocytosis","enrollment":124},{"nctId":"NCT00049595","phase":"PHASE3","title":"Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Stage III or Stage IV Hodgkin's Lymphoma","status":"COMPLETED","sponsor":"European Organisation for Research and Treatment of Cancer - EORTC","startDate":"2002-08","conditions":"Lymphoma","enrollment":552},{"nctId":"NCT00379041","phase":"PHASE3","title":"Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Previously Untreated Stage I or Stage II Hodgkin's Lymphoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"European Organisation for Research and Treatment of Cancer - EORTC","startDate":"1993-09-01","conditions":"Lymphoma","enrollment":1158},{"nctId":"NCT00002462","phase":"PHASE3","title":"RT or No RT Following Chemotherapy in Treating Patients With Stage III/IV Hodgkin's Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"European Organisation for Research and Treatment of Cancer - EORTC","startDate":"1989-09","conditions":"Lymphoma","enrollment":615},{"nctId":"NCT00005584","phase":"PHASE3","title":"Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"European Organisation for Research and Treatment of Cancer - EORTC","startDate":"1998-10","conditions":"Lymphoma","enrollment":1649},{"nctId":"NCT05008224","phase":"PHASE2","title":"Study of Safety and Efficacy of Pembrolizumab and Chemotherapy in Participants With Newly Diagnosed Classical Hodgkin Lymphoma (cHL) (MK-3475-C11/KEYNOTE-C11)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2021-10-07","conditions":"Classical Hodgkin Lymphoma","enrollment":146},{"nctId":"NCT02205762","phase":"PHASE2, PHASE3","title":"LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis","status":"RECRUITING","sponsor":"North American Consortium for Histiocytosis","startDate":"2016-11-02","conditions":"Langerhans Cell Histiocytosis","enrollment":1400},{"nctId":"NCT06486337","phase":"PHASE2","title":"CMOP±R in the Treatment of Untreated Non-Hodgkin's Lymphoma","status":"NOT_YET_RECRUITING","sponsor":"The First Affiliated Hospital of Soochow University","startDate":"2024-07-10","conditions":"NHL","enrollment":197},{"nctId":"NCT06433362","phase":"PHASE2","title":"CMOEP in the Treatment of Untreated Peripheral T-cell Lymphoma","status":"RECRUITING","sponsor":"Tianjin Medical University Cancer Institute and Hospital","startDate":"2024-06-01","conditions":"Peripheral T Cell Lymphoma","enrollment":115},{"nctId":"NCT06263530","phase":"","title":"Prognostic Significance of ctDNA in HL","status":"RECRUITING","sponsor":"Interni hematologicka klinika FNKV","startDate":"2022-01-02","conditions":"Prognostic Cancer Model","enrollment":500},{"nctId":"NCT01088750","phase":"PHASE4","title":"Surgery Alone or With CYC VBL and PRED or CVP Alone in Stage IA or IIA Nodular Lymphocyte-Predominant Hodgkin Lymphoma","status":"COMPLETED","sponsor":"Christine Mauz-Körholz","startDate":"2009-11-01","conditions":"Lymphoma","enrollment":225},{"nctId":"NCT00352027","phase":"PHASE2","title":"Chemotherapy With Low-Dose Radiation for Pediatric Hodgkin Lymphoma","status":"COMPLETED","sponsor":"St. Jude Children's Research Hospital","startDate":"2006-07-20","conditions":"Hodgkin's Lymphoma","enrollment":81},{"nctId":"NCT00488605","phase":"PHASE3","title":"H-9926-LCH III: Treatment Protocol of the Third International Study for Langerhans Cell Histiocytosis","status":"WITHDRAWN","sponsor":"University of New Mexico","startDate":"2023-08-01","conditions":"Leukemia","enrollment":""},{"nctId":"NCT00003389","phase":"PHASE3","title":"Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma","status":"COMPLETED","sponsor":"Eastern Cooperative Oncology Group","startDate":"1999-06-17","conditions":"Lymphoma","enrollment":854},{"nctId":"NCT01390584","phase":"PHASE2","title":"Chemotherapy Based on PET Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma","status":"TERMINATED","sponsor":"ECOG-ACRIN Cancer Research Group","startDate":"2013-05-24","conditions":"Lymphoma","enrollment":6},{"nctId":"NCT00822120","phase":"PHASE2","title":"S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma","status":"COMPLETED","sponsor":"SWOG Cancer Research Network","startDate":"2009-07","conditions":"Lymphoma, Nonneoplastic Condition","enrollment":371},{"nctId":"NCT01118026","phase":"PHASE2","title":"Response-Based Therapy Assessed By PET Scan in Treating Patients With Bulky Stage I and Stage II Classical Hodgkin Lymphoma","status":"COMPLETED","sponsor":"Alliance for Clinical Trials in Oncology","startDate":"2010-09","conditions":"Lymphoma","enrollment":101},{"nctId":"NCT01132807","phase":"PHASE2","title":"Chemotherapy Based on Positron Emission Tomography Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma","status":"COMPLETED","sponsor":"Alliance for Clinical Trials in Oncology","startDate":"2010-05","conditions":"Lymphoma","enrollment":164},{"nctId":"NCT02414568","phase":"PHASE2","title":"Bendamustine Study in Classical Hodgkin Lymphoma Patients Over 60 Treated by Prednisone, Vinblastine and Doxorubicin","status":"COMPLETED","sponsor":"The Lymphoma Academic Research Organisation","startDate":"2015-07-17","conditions":"Classical Hodgkin Lymphoma","enrollment":90},{"nctId":"NCT00433433","phase":"PHASE3","title":"Fludeoxyglucose F 18 PET Scan-Guided Therapy or Standard Therapy in Treating Patients With Previously Untreated Stage I or Stage II Hodgkin's Lymphoma","status":"UNKNOWN","sponsor":"European Organisation for Research and Treatment of Cancer - EORTC","startDate":"2006-10","conditions":"Lymphoma","enrollment":1952},{"nctId":"NCT00002715","phase":"PHASE2","title":"Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Lymphoma","status":"COMPLETED","sponsor":"Stanford University","startDate":"1989-04","conditions":"Lymphoma","enrollment":50},{"nctId":"NCT01356680","phase":"PHASE3","title":"HD17 for Intermediate Stage Hodgkin Lymphoma","status":"COMPLETED","sponsor":"University of Cologne","startDate":"2012-01-13","conditions":"Hodgkin Lymphoma","enrollment":1100},{"nctId":"NCT00398554","phase":"PHASE2","title":"Combination Chemotherapy in Treating Young Male Patients With Hodgkin's Lymphoma","status":"COMPLETED","sponsor":"Christine Mauz-Körholz","startDate":"2005-06","conditions":"Lymphoma","enrollment":16},{"nctId":"NCT00026208","phase":"PHASE2","title":"Combination Chemotherapy Plus Low-Dose Radiation Therapy in Treating Patients With Stage I or Stage IIA Hodgkin's Lymphoma","status":"COMPLETED","sponsor":"Stanford University","startDate":"2001-06","conditions":"Lymphoma, Hodgkin Disease, Lymphoma, Hodgkin Disease","enrollment":76},{"nctId":"NCT00024167","phase":"PHASE3","title":"Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer","status":"TERMINATED","sponsor":"M.D. Anderson Cancer Center","startDate":"2002-04","conditions":"Prostate Cancer","enrollment":265},{"nctId":"NCT00592111","phase":"PHASE2","title":"A Comprehensive Study of Clinically Staged Pediatric Hodgkin's Disease: Chemotherapy for All Patients; Supplementary Low Dose Involved Field Irradiation for Selected Patients (CCG 5942)","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"1996-03","conditions":"Pediatric, Hodgkin's Disease","enrollment":21},{"nctId":"NCT00512980","phase":"PHASE2","title":"PVAG-14 Pilot for Intermediate Stages Hodgkin Lymphoma","status":"TERMINATED","sponsor":"University of Cologne","startDate":"2008-08","conditions":"Hodgkin Lymphoma","enrollment":""},{"nctId":"NCT00795613","phase":"PHASE2","title":"Positron Emission Tomography (PET)-Adapted Chemotherapy In Advanced Hodgkin Lymphoma (HL)","status":"UNKNOWN","sponsor":"Ospedale Santa Croce-Carle Cuneo","startDate":"2008-06","conditions":"HODGKIN LYMPHOMA","enrollment":450},{"nctId":"NCT00187057","phase":"NA","title":"Study for Treatment of Cancer in Children With Ataxia-telangiectasia","status":"COMPLETED","sponsor":"St. Jude Children's Research Hospital","startDate":"2002-09","conditions":"Ataxia-Telangiectasia","enrollment":6},{"nctId":"NCT01251107","phase":"PHASE3","title":"Study Comparing ABVD vs BEACOPP in Advanced Hodgkin's Lymphoma","status":"COMPLETED","sponsor":"Fondazione Michelangelo","startDate":"2000-03","conditions":"Hodgkin Lymphoma","enrollment":331},{"nctId":"NCT00059839","phase":"PHASE3","title":"Comparison of Two Combination Chemotherapy Regimens With Either Vincristine or Vinblastine in Treating Patients With Advanced Anaplastic Large Cell Lymphoma","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2003-11","conditions":"Lymphoma","enrollment":129},{"nctId":"NCT00225173","phase":"PHASE2","title":"Combination Chemotherapy +/- Radiation in High Risk Hodgkin's Disease","status":"TERMINATED","sponsor":"Stanford University","startDate":"2001-10","conditions":"Hodgkin Disease","enrollment":45},{"nctId":"NCT00004010","phase":"PHASE2","title":"Combination Chemotherapy and Radiation Therapy in Treating Children With Previously Untreated Stage II, Stage III, or Stage IV Hodgkin's Disease","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"1999-10","conditions":"Lymphoma","enrollment":99},{"nctId":"NCT00041210","phase":"PHASE3","title":"Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Hodgkin's Lymphoma","status":"UNKNOWN","sponsor":"Mount Vernon Cancer Centre at Mount Vernon Hospital","startDate":"2001-10","conditions":"Lymphoma","enrollment":850},{"nctId":"NCT00003262","phase":"PHASE2","title":"Combination Chemotherapy in Treating Patients With Hodgkin's Disease and HIV Infection","status":"UNKNOWN","sponsor":"Centro di Riferimento Oncologico - Aviano","startDate":"1997-05","conditions":"Lymphoma","enrollment":30},{"nctId":"NCT00002714","phase":"PHASE2","title":"Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Early-Stage Hodgkin's Disease","status":"COMPLETED","sponsor":"Stanford University","startDate":"1995-04","conditions":"Lymphoma","enrollment":""},{"nctId":"NCT01468740","phase":"PHASE2","title":"Prospective Study on HIV-related Hodgkin Lymphoma","status":"UNKNOWN","sponsor":"Harlachinger Krebshilfe e.V.","startDate":"2004-03","conditions":"HIV-associated Hodgkin Lymphoma","enrollment":130},{"nctId":"NCT00264953","phase":"PHASE3","title":"HD11 for Intermediate Stages","status":"COMPLETED","sponsor":"University of Cologne","startDate":"1998-05","conditions":"Hodgkin´s Lymphoma","enrollment":1395},{"nctId":"NCT01148446","phase":"PHASE3","title":"R-CHOP Versus R-mini-CEOP in Elderly Patients(>65)With DLBCL","status":"COMPLETED","sponsor":"Fondazione Italiana Linfomi - ETS","startDate":"2003-01","conditions":"Elderly Patients (>65 Years), Diffuse Large B Cell Lymphoma (DLBCL)","enrollment":226},{"nctId":"NCT00970385","phase":"PHASE3","title":"Study About Treatment of Newly Diagnosed Non Cutaneous Peripheral T Cell Lymphoma","status":"COMPLETED","sponsor":"University Hospital, Grenoble","startDate":"1995-01","conditions":"Peripheral T Cell Lymphoma","enrollment":95},{"nctId":"NCT00147875","phase":"PHASE1, PHASE2","title":"Study of Prednisone, Vinblastine, Doxorubicin, and Gemcitabine in Elderly Patients With Advanced Stages Hodgkin's Lymphoma","status":"COMPLETED","sponsor":"University of Cologne","startDate":"2004-03","conditions":"Hodgkin's Disease","enrollment":60},{"nctId":"NCT00187070","phase":"NA","title":"Large Cell Lymphoma Pilot Study III","status":"COMPLETED","sponsor":"St. Jude Children's Research Hospital","startDate":"1997-12","conditions":"Lymphoma, Large Cell, Lymphoma, Non-Hodgkin","enrollment":8}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":9,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Velban/Deltasone"],"phase":"phase_3","status":"active","brandName":"Vinblastine/prednisone","genericName":"Vinblastine/prednisone","companyName":"Baylor College of Medicine","companyId":"baylor-college-of-medicine","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Vinblastine is used in combination with other treatments, including prednisone, to study various types of lymphoma in clinical trials. The exact mechanism of action of vinblastine is not specified in the provided information, but it is listed as an intervention in trials for lymphoma conditions.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}